Adrenergic regulation of innate immunity: A review

Frontiers in Pharmacology

Volumn 6, Issue Aug, 2015, Pages

  Scanzano, Angela ^a   Cosentino, Marco ^a  

^a UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

Adrenaline; Adrenoceptors; Immunity of CNS; Innate immunity; Noradrenaline

Indexed keywords

ADRENALIN; ADRENERGIC RECEPTOR; ADRENERGIC RECEPTOR STIMULATING AGENT; ALFUZOSIN; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR; CD11B ANTIGEN; CD18 ANTIGEN; CLENBUTEROL; CPG OLIGODEOXYNUCLEOTIDE; CYCLOOXYGENASE 2 INHIBITOR; DEXMEDETOMIDINE; DOXAZOSIN; FLUOXETINE; IMMUNOMODULATING AGENT; METHOXAMINE; MIDODRINE; NORADRENALIN; OXYMETAZOLINE; PHENOXYBENZAMINE; PHENTOLAMINE; POLYPEPTIDE ANTIBIOTIC AGENT; PRAZOSIN; PROPRANOLOL; TAMSULOSIN; TERAZOSIN; TRAZODONE; UNINDEXED DRUG;

ADRENERGIC SYSTEM; AEROBIC METABOLISM; ANTIGEN EXPRESSION; ASTHMA; ASTROCYTE; AUTOIMMUNE DISEASE; BRAIN; CD4+ T LYMPHOCYTE; CELL INTERACTION; CELL MIGRATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; DEGENERATIVE DISEASE; DENDRITIC CELL; DRUG REPOSITIONING; DRUG TARGETING; HUMAN; HYPERTENSION; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; IMMUNOREGULATION; INNATE IMMUNITY; LYMPHOCYTE DIFFERENTIATION; MICROGLIA; MONOCYTE; NATURAL KILLER CELL; NERVOUS SYSTEM INFLAMMATION; NEUTROPHIL; NONHUMAN; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; REVIEW; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

EID: 84940827427     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2015.00171     Document Type: Review

References (218)

1. Ahlquist, R. P. (1948). A study of the adrenotropic receptors. Am. J. Physiol. 153, 586-600.
2. Anane, L. H., Edwards, K. M., Burns, V. E., Drayson, M. T., and Bosch, J. A. (2009). Mobilization of gammadelta T lymphocytes in response to psychological stress, exercise, and beta-agonist infusion. Brain Behav. Immun. 23, 823-829. doi: 10.1016/j.bbi.2009.03.003
3. Arias-Montaño, J. A., Berger, V. A., Soria-Jasso, L. E., and Young, J. M. (1999). Characterisation of alpha1B-adrenoceptors linked to inositol phosphate formation and calcium mobilisation in human astrocytoma U373 MG cells. Naunyn Schmiedebergs Arch. Pharmacol. 360, 533-539.
4. Armaiz-Pena, G. N., Gonzalez-Villasana, V., Nagaraja, A. S., Rodriguez-Aguayo, C., Sadaoui, N. C., Stone, R. L., et al. (2015). Adrenergic regulation of monocyte chemotactic protein 1 leads to enhanced macrophage recruitment and ovarian carcinoma growth. Oncotarget 6, 4266-4273.
5. Auffray, C., Sieweke, M. H., and Geissmann, F. (2009). Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu. Rev. Immunol. 27, 669-692. doi: 10.1146/annurev.immunol.021908.132557
6. Baker, A. J., and Fuller, R. W. (1995). Loss of response to beta-adrenoceptor agonists during the maturation of human monocytes to macrophages in vitro. J. Leukoc. Biol. 57, 395-400.
7. Balsa, M. D., Gómez, N., and Unzeta, M. (1989). Characterization of monoamine oxidase activity present in human granulocytes and lymphocytes. Biochim. Biophys. Acta 992, 140-144. doi: 10.1016/0304-4165(89)90002-0
8. Barnes, P. J. (1993). Beta-adrenoceptors on smooth muscle, nerves and inflammatory cells. Life Sci. 52, 2101-2109. doi: 10.1016/0024-3205(93)90725-I
9. Ben-Eliyahu, S. (2012). Can we really know if a stressor increases or decreases natural killer cell activity? Brain Behav. Immun. 26, 1224-1225. doi: 10.1016/j.bbi.2012.08.004
10. Ben-Eliyahu, S., Shakhar, G., Page, G. G., Stefanski, V., and Shakhar, K. (2000). Suppression of NK cell activity and of resistance to metastasis by stress: a role for adrenal catecholamines and beta-adrenoceptors. Neuroimmunomodulation 8, 154-164. doi: 10.1159/000054276
11. Benschop, R. J., Nijkamp, F. P., Ballieux, R. E., and Heijnen, C. J. (1994). The effects of beta-adrenoceptor stimulation on adhesion of human natural killer cells to cultured endothelium. Br. J. Pharmacol. 113, 1311-1316.
12. Benschop, R. J., Schedlowski, M., Wienecke, H., Jacobs, R., and Schmidt, R. E. (1997). Adrenergic control of natural killer cell circulation and adhesion. Brain Behav. Immun. 11, 321-332. doi: 10.1006/brbi.1997.0499
13. Biswas, S. K., and Mantovani, A. (2010). Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat. Immunol. 11, 889-896. doi: 10.1038/ni.1937
14. Boman, H. G. (2003). Antimicrobial peptides: basic facts and emerging concepts. J. Intern. Med. 254, 197-215. doi: 10.1046/j.1365-2796.2003.01228.x
15. Borda, E. S., Tenenbaum, A., Sales, M. E., Rumi, L., and Sterin-Borda, L. (1998). Role of arachidonic acid metabolites in the action of a beta adrenergic agonist on human monocyte phagocytosis. Prostaglandins Leukot. Essent. Fatty Acids 58, 85-90. doi: 10.1016/S0952-3278(98)90145-4
16. Botta, F., and Maestroni, G. J. (2008). Adrenergic modulation of dendritic cell cancer vaccine in a mouse model: role of dendritic cell maturation. J. Immunother. 31, 263-270. doi: 10.1097/CJI.0b013e318160995e
17. Boutajangout, A., and Wisniewski, T. (2013). The innate immune system in Alzheimer's disease. Int. J. Cell Biol. 2013:576383. doi: 10.1155/2013/576383
18. Bowden Sulakvelidze, I., and McDonald, D. M. (1994). Inhibition of neutrophil and eosinophil adhesion to venules of rat trachea by beta 2-adrenergic agonist formoterol. J. Appl. Physiol. 77, 397-405.
19. Brenner, G. J., Felten, S. Y., Felten, D. L., and Moynihan, J. A. (1992). Sympathetic nervous system modulation of tumor metastases and host defense mechanisms. J. Neuroimmunol. 37, 191-201.
20. Brunskole Hummel, I., Reinartz, M. T., Kälble, S., Burhenne, H., Schwede, F., Seifert, R., et al. (2013). Dissociations in the effects of β2-adrenergic receptor agonists on cAMP formation and superoxide production in human neutrophils: support for the concept of functional selectivity. PLoS ONE 8:e64556. doi: 10.1371/journal.pone.0064556
21. Bylund, D. B., Eikenberg, D. C., Hieble, J. P., Langer, S. Z., Lefkowitz, R. J., Minneman, K. P., et al. (1994). International union of pharmacology nomenclature of adrenoceptors. Pharmacol. Rev. 46, 121-136.
22. Carding, S. R., and Egan, P. J. (2002). Gammadelta T cells: functional plasticity and heterogeneity. Nat. Rev. Immunol. 2, 336-345. doi: 10.1038/nri797
23. Chaitidis, P., Billett, E. E., O'Donnell, V. B., Fajardo, A. B., Fitzgerald, J., Kuban, R. J., et al. (2004). Th2 response of human peripheral monocytes involves isoform-specific induction of monoamine oxidase-A. J. Immunol. 173, 4821-4827. doi: 10.4049/jimmunol.173.8.4821
24. Chaitidis, P., O'Donnell, V., Kuban, R. J., Bermudez-Fajardo, A., Ungethuem, U., and Kühn, H. (2005). Gene expression alterations of human peripheral blood monocytes induced by medium-term treatment with the TH2-cytokines interleukin-4 and -13. Cytokine 30, 366-377. doi: 10.1016/j.cyto.2005.02.004
25. Chávez-Sánchez, L., Espinosa-Luna, J. E., Chávez-Rueda, K., Legorreta-Haquet, M. V., Montoya-Díaz, E., and Blanco-Favela, F. (2014). Innate immune system cells in atherosclerosis. Arch. Med. Res. 45, 1-14. doi: 10.1016/j.arcmed.2013.11.007
26. Chijioke, O., and Münz, C. (2013). Dendritic cell derived cytokines in human natural killer cell differentiation and activation. Front. Immunol. 4:365. doi: 10.3389/fimmu.2013.00365
27. Choi, C. H., Song, T., Kim, T. H., Choi, J. K., Park, J. Y., Kim, B. G., et al. (2014). Meta-analysis of the effects of beta blocker on survival time in cancer patients. J. Cancer Res. Clin. Oncol. 140, 1179-1188. doi: 10.1007/s00432-014-1658-7
28. Chong, L. K., Chess-Williams, R., and Peachell, P. T. (2002). Pharmacological characterisation of the beta-adrenoceptor expressed by human lung mast cells. Eur. J. Pharmacol. 437, 1-7. doi: 10.1016/S0014-2999(02)01263-3
29. Chong, L. K., Chowdry, J., Ghahramani, P., and Peachell, P. T. (2000). Influence of genetic polymorphisms in the betα2-adrenoceptor on desensitization in human lung mast cells. Pharmacogenetics 10, 153-162. doi: 10.1097/00008571-200003000-00007
30. Chong, L. K., Morice, A. H., Yeo, W. W., Schleimer, R. P., and Peachell, P. T. (1995). Functional desensitization of beta agonist responses in human lung mast cells. Am. J. Respir. Cell Mol. Biol. 13, 540-546. doi: 10.1165/ajrcmb.13.5.7576689
31. Chou, R. C., Dong, X. L., Noble, B. K., Knight, P. R., and Spengler, R. N. (1998). Adrenergic regulation of macrophage-derived tumor necrosis factor-alpha generation during a chronic polyarthritis pain model. J. Neuroimmunol. 82, 140-148. doi: 10.1016/S0165-5728(97)00196-3
32. Cnop, M., Welsh, N., Jonas, J. C., Jörns, A., Lenzen, S., and Eizirik, D. L. (2005). Mechanisms of pancreatic beta-cell death in Type 1 and Type 2 diabetes: many differences, few similarities. Diabetes 54(Suppl. 2), S97-S107. doi: 10.2337/diabetes.54.suppl_2.S97
33. Corradi, L., Negri, F., Parini, A., Partesana, N., and Finardi, G. (1981). Decreased beta-adrenoceptors in polymorphonucleates in essential hypertension. Boll. Soc. Ital. Biol. Sper. 57, 1766-1770.
34. Cosentino, M., and Marino, F. (2013). Adrenergic and dopaminergic modulation of immunity in multiple sclerosis: teaching old drugs new tricks? J. Neuroimmune Pharmacol. 8, 163-179. doi: 10.1007/s11481-012-9410-z
35. Cosentino, M., Marino, F., Bombelli, R., Ferrari, M., Lecchini, S., and Frigo, G. (1999). Endogenous catecholamine synthesis, metabolism, storage and uptake in human neutrophils. Life Sci. 64, 975-981. doi: 10.1016/S0024-3205(99)00023-5
36. Cotter, T. G., and O'Malley, K. (1983). Decreased neutrophil cyclic AMP response to isoprenaline stimulation in the elderly. Clin Sci. (Lond.) 65, 155-157.
37. Courties, G., Moskowitz, M. A., and Nahrendorf, M. (2014). The innate immune system after ischemic injury: lessons to be learned from the heart and brain. JAMA Neurol. 71, 233-236. doi: 10.1001/jamaneurol.2013.5026
38. Cruse, G., Yang, W., Duffy, S. M., Chachi, L., Leyland, M., Amrani, Y., et al. (2010). Counterregulation of beta(2)-adrenoceptor function in human mast cells by stem cell factor. J. Allergy Clin. Immunol. 125, 257-63.e1-5. doi: 10.1016/j.jaci.2009.08.020
39. da Silva, E. Z., Jamur, M. C., and Oliver, C. (2014). Mast cell function: a new vision of an old cell. J. Histochem. Cytochem. 62, 698-738. doi: 10.1369/0022155414545334
40. De Giorgi, V., Grazzini, M., Gandini, S., Benemei, S., Lotti, T., Marchionni, N., et al. (2011). Treatment with β-blockers and reduced disease progression in patients with thick melanoma. Arch. Intern. Med. 171, 779-781. doi: 10.1001/archinternmed.2011.131
41. De Keyser, J., Laureys, G., Demol, F., Wilczak, N., Mostert, J., and Clinckers, R. (2010). Astrocytes as potential targets to suppress inflammatory demyelinating lesions in multiple sclerosis. Neurochem. Int. 57, 446-450. doi: 10.1016/j.neuint.2010.02.012
42. De Keyser, J., Steen, C., Mostert, J. P., and Koch, M. W. (2008). Hypoperfusion of the cerebral white matter in multiple sclerosis: possible mechanisms and pathophysiological significance. J. Cereb. Blood Flow Metab. 28, 1645-1651. doi: 10.1038/jcbfm.2008.72
43. De Keyser, J., Wilczak, N., Leta, R., and Streetland, C. (1999). Astrocytes in multiple sclerosis lack beta-2 adrenergic receptors. Neurology 53, 1628-1633. doi: 10.1212/WNL.53.8.1628
44. De Keyser, J., Zeinstra, E., and Frohman, E. (2003). Are astrocytes central players in the pathophysiology of multiple sclerosis? Arch. Neurol. 60, 132-136. doi: 10.1001/archneur.60.1.132
45. De Keyser, J., Zeinstra, E., and Wilczak, N. (2004). Astrocytic betα2-adrenergic receptors and multiple sclerosis. Neurobiol. Dis. 15, 331-339. doi: 10.1016/j.nbd.2003.10.012
46. De Kleer, I., Willems, F., Lambrecht, B., and Goriely, S. (2014). Ontogeny of myeloid cells. Front. Immunol. 5:423. doi: 10.3389/fimmu.2014.00423
47. Del Rio-Hortega, P. (1932). "Microglia," in Cytology and Cellular Pathology of the Nervous System, ed W. Penfield (New York, NY: Hoeber), 482-534.
48. Dimitrov, S., Lange, T., and Born, J. (2010). Selective mobilization of cytotoxic leukocytes by epinephrine. J. Immunol. 184, 503-511. doi: 10.4049/jimmunol.0902189
49. Du, Y., Yan, L., Du, H., Wang, L., Ding, F., Quan, L., et al. (2012). β1 -adrenergic receptor autoantibodies from heart failure patients enhanced TNF-a secretion in RAW264.7 macrophages in a largely PKA-dependent fashion. J. Cell. Biochem. 113, 3218-3228. doi: 10.1002/jcb.24198
50. Elenkov, I. J., Wilder, R. L., Chrousos, G. P., and Vizi, E. S. (2000). The sympathetic nerve-an integrative interface between two supersystems: the brain and the immune system. Pharmacol. Rev. 52, 595-638.
51. Endo, F., Komine, O., Fujimori-Tonou, N., Katsuno, M., Jin, S., Watanabe, S., et al. (2015). Astrocyte-derived TGF-β1 accelerates disease progression in ALS mice by interfering with the neuroprotective functions of microglia and T cells. Cell Rep. 11, 592-604. doi: 10.1016/j.celrep.2015.03.053
52. Ezeamuzie, C. I., Shihab, P. K., and Al-Radwan, R. (2011). Loss of surface beta-2 adrenoceptors accounts for the insensitivity of cultured human monocytes to beta-2 adrenoceptor agonists. Int. Immunopharmacol. 11, 1189-1194. doi: 10.1016/j.intimp.2011.03.017
53. Farrar, C. A., Kupiec-Weglinski, J. W., and Sacks, S. H. (2013). The innate immune system and transplantation. Cold Spring Harb. Perspect. Med. 3:a015479. doi: 10.1101/cshperspect.a015479
54. Feldman, R. S., Meyer, J. S., and Quenzer, L. F. (eds.). (1997). "Catecholamines," in Principles of Neuropsychopharmacology (Sunderland, MA: Sinauer Associates Inc), 277-344.
55. Flierl, M. A., Rittirsch, D., Chen, A. J., Nadeau, B. A., Day, D. E., Sarma, J. V., et al. (2008b). The complement anaphylatoxin C5a induces apoptosis in adrenomedullary cells during experimental sepsis. PLoS ONE 3:e2560. doi: 10.1371/journal.pone.0002560
56. Flierl, M. A., Rittirsch, D., Nadeau, B. A., Chen, A. J., Sarma, J. V., Zetoune, F. S., et al. (2007). Phagocyte-derived catecholamines enhance acute inflammatory injury. Nature 449, 721-725. doi: 10.1038/nature06185
57. Flierl, M. A., Rittirsch, D., Nadeau, B. A., Sarma, J. V., Day, D. E., Lentsch, A. B., et al. (2009). Upregulation of phagocyte-derived catecholamines augments the acute inflammatory response. PLoS ONE 4:e4414. doi: 10.1371/journal.pone.0004414
58. Flierl, M. A., Rittirsch, D., Sarma, J. V., Huber-Lang, M., and Ward, P. A. (2008a). Adrenergic regulation of complement-induced acute lung injury. Adv. Exp. Med. Biol. 632, 93-103. doi: 10.1007/978-0-387-78952-1_8
59. Fragala, M. S., Kraemer, W. J., Mastro, A. M., Denegar, C. R., Volek, J. S., Häkkinen, K., et al. (2011). Leukocyte β2-adrenergic receptor expression in response to resistance exercise. Med. Sci. Sports Exerc. 43, 1422-1432. doi: 10.1249/MSS.0b013e31820b88bc
60. Gantt, S., Gervassi, A., Jaspan, H., and Horton, H. (2014). The role of myeloid-derived suppressor cells in immune ontogeny. Front. Immunol. 5:387. doi: 10.3389/fimmu.2014.00387
61. Gauthier, C., Tavernier, G., Charpentier, F., Langin, D., and Lemarec, H. (1996). Functional beta (3)-adrenoceptor in the human heart. J. Clin. Invest. 98, 556-562. doi: 10.1172/JCI118823
62. Gebhardt, T., Gerhard, R., Bedoui, S., Erpenbeck, V. J., Hoffmann, M. W., Manns, M. P., et al. (2005). betα2-Adrenoceptor-mediated suppression of human intestinal mast cell functions is caused by disruption of filamentous actin dynamics. Eur. J. Immunol. 35, 1124-1132. doi: 10.1002/eji.200425869
63. Geissmann, F., Manz, M. G., Jung, S., Sieweke, M. H., Merad, M., and Ley, K. (2010). Development of monocytes, macrophages, and dendritic cells. Science 327, 656-661. doi: 10.1126/science.1178331
64. Glac, W., Borman, A., Badtke, P., Stojek, W., Orlikowska, A., and Tokarski, J. (2006). Amphetamine enhances natural killer cytotoxic activity via beta-adrenergic mechanism. J. Physiol. Pharmacol. 11, 125-132.
65. Goldfarb, Y., Benish, M., Rosenne, E., Melamed, R., Levi, B., Glasner, A., et al. (2009). CpG-C oligodeoxynucleotides limit the deleterious effects of beta-adrenoceptor stimulation on NK cytotoxicity and metastatic dissemination. J. Immunother. 32, 280-291. doi: 10.1097/CJI.0b013e31819a2982
66. Goldfarb, Y., Sorski, L., Benish, M., Levi, B., Melamed, R., and Ben-Eliyahu, S. (2011). Improving postoperative immune status and resistance to cancer metastasis: a combined perioperative approach of immunostimulation and prevention of excessive surgical stress responses. Ann. Surg. 253, 798-810. doi: 10.1097/SLA.0b013e318211d7b5
67. Goyarts, E., Matsui, M., Mammone, T., Bender, A. M., Wagner, J. A., Maes, D., et al. (2008). Norepinephrine modulates human dendritic cell activation by altering cytokine release. Exp. Dermatol. 17, 188-196. doi: 10.1111/j.1600-0625.2007.00677.x
68. Grisanti, L. A., Evanson, J., Marchus, E., Jorissen, H., Woster, A. P., DeKrey, W., et al. (2010). Pro-inflammatory responses in human monocytes are betα1-adrenergic receptor subtype dependent. Mol. Immunol. 47, 1244-1254. doi: 10.1016/j.molimm.2009.12.013
69. Grisanti, L. A., Woster, A. P., Dahlman, J., Sauter, E. R., Combs, C. K., and Porter, J. E. (2011). {alpha}1-adrenergic receptors positively regulate toll-like receptor cytokine production from human monocytes and macrophages. J. Pharmacol. Exp. Ther. 338, 648-657. doi: 10.1124/jpet.110.178012
70. Gross, C. A., Bowler, R. P., Green, R. M., Weinberger, A. R., Schnell, C., and Chu, H. W. (2010). Betα2-agonists promote host defense against bacterial infection in primary human bronchial epithelial cells. BMC Pulm. Med. 10:30. doi: 10.1186/1471-2466-10-30
71. Guimarães, S., and Moura, D. (2001). Vascular adrenoceptors: an update. Pharmacol. Rev. 53, 319-356.
72. Guirao, X., Kumar, A., Katz, J., Smith, M., Lin, E., Keogh, C., et al. (1997). Catecholamines increase monocyte TNF receptors and inhibit TNF through beta 2-adrenoreceptor activation. Am. J. Physiol. 273, E1203-E1208.
73. Gurguis, G. N., Andrews, R., Antai-Otong, D., Vo, S. P., Blakeley, J. E., Orsulak, P. J., et al. (1999). Neutrophil betα2-adrenergic receptor coupling efficiency to Gs protein in subjects with post-traumatic stress disorder and normal controls. Psychopharmacology (Berl.) 143, 131-140. doi: 10.1007/s002130050928
74. Harms, H. H., Zaagsma, J., and Van der Wal, B. (1974). β-Adrenoceptor studies. III. On the β-adrenoceptors in rat adipose tissue. Eur. J. Pharmacol. 25, 87-91. doi: 10.1016/0014-2999(74)90098-3
75. Heidt, T., Sager, H. B., Courties, G., Dutta, P., Iwamoto, Y., Zaltsman, A., et al. (2014). Chronic variable stress activates hematopoietic stem cells. Nat. Med. 20, 754-758. doi: 10.1038/nm.3589
76. Heijnen, C. J., Rouppe van der Voort, C., van de Pol, M., and Kavelaars, A. (2002). Cytokines regulate alpha(1)-adrenergic receptor mRNA expression in human monocytic cells and endothelial cells. J. Neuroimmunol. 125, 66-72. doi: 10.1016/S0165-5728(02)00034-6
77. Hellstrand, K., Hermodsson, S., and Strannegård, O. (1985). Evidence for a beta-adrenoceptor-mediated regulation of human natural killer cells. J. Immunol. 134, 4095-4099.
78. Hertz, L., Lovatt, D., Goldman, S. A., and Nedergaard, M. (2010). Adrenoceptors in brain: cellular gene expression and effects on astrocytic metabolism and [Ca(2+)]i. Neurochem. Int. 57, 411-420. doi: 10.1016/j.neuint.2010.03.019
79. Hervé, J., Dubreil, L., Tardif, V., Terme, M., Pogu, S., Anegon, I., et al. (2013). β2-Adrenoreceptor agonist inhibits antigen cross-presentation by dendritic cells. J. Immunol. 190, 3163-3171. doi: 10.4049/jimmunol.1201391
80. Humphreys, R. J., and Raab, W. (1950). Response of circulating eosinophils to nor-epinephrine, epinephrine and emotional stress in humans. Proc. Soc. Exp. Biol. Med. 74, 302-303. doi: 10.3181/00379727-74-17884
81. Inbar, S., Neeman, E., Avraham, R., Benish, M., Rosenne, E., and Ben-Eliyahu, S. (2011). Do stress responses promote leukemia progression? An animal study suggesting a role for epinephrine and prostaglandin-E2 through reduced NK activity. PLoS ONE 6:e19246. doi: 10.1371/journal.pone.0019246
82. Izeboud, C. A., Mocking, J. A., Monshouwer, M., van Miert, A. S., and Witkamp, R. F. (1999). Participation of beta-adrenergic receptors on macrophages in modulation of LPS-induced cytokine release. J. Recept. Signal Transduct. Res. 19, 191-202.
83. Jetschmann, J. U., Benschop, R. J., Jacobs, R., Kemper, A., Oberbeck, R., Schmidt, R. E., et al. (1997). Expression and in-vivo modulation of alpha- and beta-adrenoceptors on human natural killer (CD16+) cells. J. Neuroimmunol. 74, 159-164. doi: 10.1016/S0165-5728(96)00221-4
84. Jones, K. A., and Thomsen, C. (2013). The role of the innate immune system in psychiatric disorders. Mol. Cell. Neurosci. 53, 52-62. doi: 10.1016/j.mcn.2012.10.002
85. Kalinichenko, V. V., Mokyr, M. B., Graf, L. H. Jr., Cohen, R. L., and Chambers, D. A. (1999). Norepinephrine-mediated inhibition of antitumor cytotoxic T lymphocyte generation involves a beta-adrenergic receptor mechanism and decreased TNF-alpha gene expression. J. Immunol. 163, 2492-2499.
86. Kanemi, O., Zhang, X., Sakamoto, Y., Ebina, M., and Nagatomi, R. (2005). Acute stress reduces intraparenchymal lung natural killer cells via beta-adrenergic stimulation. Clin. Exp. Immunol. 139, 25-34. doi: 10.1111/j.1365-2249.2005.02672.x
87. Karasuyama, H., and Yamanishi, Y. (2014). Basophils have emerged as a key player in immunity. Curr. Opin. Immunol. 31C, 1-7. doi: 10.1016/j.coi.2014.07.004
88. Katsumoto, A., Lu, H., Miranda, A. S., and Ransohoff, R. M. (2014). Ontogeny and Functions of Central Nervous System Macrophages. J. Immunol. 193, 2615-2621. doi: 10.4049/jimmunol.1400716
89. Kavelaars, A., van de Pol, M., Zijlstra, J., and Heijnen, C. J. (1997). Beta 2-adrenergic activation enhances interleukin-8 production by human monocytes. J. Neuroimmunol. 77, 211-216.
90. Kawai, T., and Akira, S. (2010). The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 11, 373-384. doi: 10.1038/ni.1863
91. Kay, L. J., and Peachell, P. T. (2005). Mast cell betα2-adrenoceptors. Chem. Immunol. Allergy 87, 145-153. doi: 10.1159/000087641
92. Kenney, M. J., and Ganta, C. K. (2014). Autonomic nervous system and immune system interactions. Compr. Physiol. 4, 1177-1200. doi: 10.1002/cphy.c130051
93. Kettenmann, H., Hanish, U. K., Noda, M., and Verkhratsky, A. (2011). Physiology of microglia. Physiol. Rev. 91, 461-553. doi: 10.1152/physrev.00011.2010
94. Kim, B. J., and Jones, H. P. (2010). Epinephrine-primed murine bone marrow-derived dendritic cells facilitate production of IL-17A and IL-4 but not IFN-? by CD4+ T cells. Brain Behav. Immun. 24, 1126-1136. doi: 10.1016/j.bbi.2010.05.003
95. Kimelberg, H. K., and Nedergaard, M. (2010). Functions of astrocytes and their potential as therapeutic targets. Neurotherapeutics 7, 338-353. doi: 10.1016/j.nurt.2010.07.006
96. Kita, H. (2013). Eosinophils: multifunctional and distinctive properties. Int. Arch. Allergy Immunol. 2, 3-9. doi: 10.1159/000350662
97. Kobayashi, M., Jeschke, M. G., Asai, A., Kogiso, M., Yoshida, S., Herndon, D. N., et al. (2011). Propranolol as a modulator of M2b monocytes in severely burned patients. J. Leukoc. Biol. 89, 797-803. doi: 10.1189/jlb.1010553
98. Koch-Weser, J. (1968). Beta adrenergic blockade and circulating eosinophils. Arch. Intern. Med. 121, 255-258. doi: 10.1001/archinte.1968.03640030047007
99. Kohm, A. P., and Sanders, V. M. (2001). Norepinephrine and beta 2-adrenergic receptor stimulation regulate CD4+ T and B lymphocyte function in vitro and in vivo. Pharmacol. Rev. 53, 487-525.
100. Kong, Y., Ruan, L., Qian, L., Liu, X., and Le, Y. (2010). Norepinephrine promotes microglia to uptake and degrade amyloid beta peptide through upregulation of mouse formyl peptide receptor 2 and induction of insulin-degrading enzyme. J. Neurosci. 30, 11848-11857. doi: 10.1523/JNEUROSCI.2985-10.2010
101. Kozlov, L. V., and Lebedeva, T. V. (1998). Inhibition of formation of complement C5-convertase. Bioorg. Khim. 24, 350-355.
102. Kozlov, L. V., Lakhtin, V. M., Skorokhodova, T. G., Batalova, T. N., Shoibonov, B. B., D'Iakov, V. L., et al. (2000). Inhibition of binding of activated compliment component C4b with its target. Bioorg. Khim. 26, 817-824.
103. Kuebler, U., Wirtz, P. H., Sakai, M., Stemmer, A., and Ehlert, U. (2013). Acute stress reduces wound-induced activation of microbicidal potential of ex vivo isolated human monocyte-derived macrophages. PLoS ONE 8:e55875. doi: 10.1371/journal.pone.0055875
104. Lanier, L. L. (2008). Up on the tightrope: natural killer cell activation and inhibition. Nat. Immunol. 9, 495-502. doi: 10.1038/ni1581
105. Lappin, D., and Whaley, K. (1982). Adrenergic receptors on monocytes modulate complement component synthesis. Clin. Exp. Immunol. 47, 606-612.
106. Laureys, G., Clinckers, R., Gerlo, S., Spooren, A., Wilczak, N., Kooijman, R., et al. (2010). Astrocytic beta (2)-adrenergic receptors: from physiology to pathology. Prog. Neurobiol. 91, 189-199. doi: 10.1016/j.pneurobio.2010.01.011
107. Laureys, G., Gerlo, S., Spooren, A., Demol, F., De Keyser, J., and Aerts, J. L. (2014). β2-adrenergic agonists modulate TNF-a induced astrocytic inflammatory gene expression and brain inflammatory cell populations. J. Neuroinflammation 11:21. doi: 10.1186/1742-2094-11-21
108. Le Provost, G. S., and Pullar, C. E. (2015). β2-adrenoceptor activation modulates skin wound healing processes to reduce scarring. J. Invest. Dermatol. 135, 279-288. doi: 10.1038/jid.2014.312
109. Lee, M. S. (2014). Role of innate immunity in the pathogenesis of type 1 and type 2 diabetes. J. Korean Med. Sci. 29, 1038-1041. doi: 10.3346/jkms.2014.29.8.1038
110. Lee, S. Y., Kim, D. K., Kim, K. D., Myung, S. C., and Lee, M. Y. (2011). The relaxing effect of a-defensin 1 on the adrenergic responses of rat bladder. Korean J. Physiol. Pharmacol. 15, 143-147. doi: 10.4196/kjpp.2011.15.3.143
111. Levine, A. P., and Segal, A. W. (2013). What is wrong with granulocytes in inflammatory bowel diseases? Dig. Dis. 31, 321-327. doi: 10.1159/000354686
112. Li, C. Y., Chou, T. C., Lee, C. H., Tsai, C. S., Loh, S. H., and Wong, C. S. (2003). Adrenaline inhibits lipopolysaccharide-induced macrophage inflammatory protein-1 alpha in human monocytes: the role of beta-adrenergic receptors. Anesth. Analg. 96, 518-523. doi: 10.1213/00000539-200302000-00040
113. Loegering, D. J., and Commins, L. M. (1988). Effect of beta-receptor stimulation on Kupffer cell complement receptor clearance function. Circ. Shock 25, 325-332.
114. Lumeng, C. N. (2013). Innate immune activation in obesity. Mol. Aspects Med. 34, 12-29. doi: 10.1016/j.mam.2012.10.002
115. Maestroni, G. J. (2004). Modulation of skin norepinephrine turnover by allergen sensitization: impact on contact hypersensitivity and T helper priming. J. Inverst. Dermatol. 122, 119-124. doi: 10.1046/j.0022-202X.2003.22132.x
116. Maestroni, G. J. (2005). Adrenergic modulation of dendritic cells function: relevance for the immune homeostasis. Curr. Neurovasc. Res. 2, 169-173. doi: 10.2174/1567202053586776
117. Maestroni, G. J. (2006). Sympathetic nervous system influence on the innate immune response. Ann. N.Y. Acad. Sci. 1069, 195-207. doi: 10.1196/annals.1351.017
118. Maisel, A. S., Harris, T., Rearden, C. A., and Michel, M. C. (1990). Beta-adrenergic receptors in lymphocyte subsets after exercise. Alterations in normal individuals and patients with congestive heart failure. Circulation 82, 2003-2010.
119. Mannaioni, P. F., Mastroianni, R., and Mastrangelo, D. (2010). Adrenaline inhibits the immunological activation of human basophils at pharmacological and ultra-low doses. Med. Sci. Monit. 16, BR227-BR232.
120. Manni, M., and Maestroni, G. J. (2008). Sympathetic nervous modulation of the skin innate and adaptive immune response to peptidoglycan but not lipopolysaccharide: involvement of beta-adrenoceptors and relevance in inflammatory diseases. Brain Behav. Immun. 22, 80-88. doi: 10.1016/j.bbi.2007.06.016
121. Manni, M., Granstein, R. D., and Maestroni, G. (2011). β2-Adrenergic agonists bias TLR-2 and NOD2 activated dendritic cells towards inducing an IL-17 immune response. Cytokine 55, 380-386. doi: 10.1016/j.cyto.2011.05.013
122. Manning, C. D., McLaughlin, M. M., Livi, G. P., Cieslinski, L. B., Torphy, T. J., and Barnette, M. S. (1996). Prolonged beta adrenoceptor stimulation up-regulates cAMP phosphodiesterase activity in human monocytes by increasing mRNA and protein for phosphodiesterases 4A and 4B. J. Pharmacol. Exp. Ther. 276, 810-818.
123. Mantyh, P. W., Rogers, S. D., Allen, C. J., Catton, M. D., Ghilardi, J. R., Levin, L. A., et al. (1995). Beta 2-adrenergic receptors are expressed by glia in vivo in the normal and injured central nervous system in the rat, rabbit, and human. J. Neurosci. 15, 152-164.
124. Marcus, A., Gowen, B. G., Thompson, T. W., Iannello, A., Ardolino, M., Deng, W., et al. (2014). Recognition of tumors by the innate immune system and natural killer cells. Adv. Immunol. 122, 91-128. doi: 10.1016/B978-0-12-800267-4.00003-1
125. Marino, F., and Cosentino, M. (2013). Adrenergic modulation of immune cells: an update. Amino Acids 45, 55-71. doi: 10.1007/s00726-011-1186-6
126. Marino, F., Tozzi, M., Schembri, L., Ferraro, S., Tarallo, A., Scanzano, A., et al. (2015). Production of IL-8, VEGF and elastase by circulating and intraplaque neutrophils in patients with carotid atherosclerosis. PLoS ONE 10:e0124565. doi: 10.1371/journal.pone.0124565
127. Markus, T., Hansson, S. R., Cronberg, T., Cilio, C., Wieloch, T., and Ley, D. (2010). β-Adrenoceptor activation depresses brain inflammation and is neuroprotective in lipopolysaccharide-induced sensitization to oxygen-glucose deprivation in organotypic hippocampal slices. J. Neuroinflammation 7:94. doi: 10.1186/1742-2094-7-94
128. Martin-Ezquerra, G., Man, M. Q., Hupe, M., Rodriguez-Martin, M., Youm, J. K., Trullas, C., et al. (2011). Psychological stress regulates antimicrobial peptide expression by both glucocorticoid and β-adrenergic mechanisms. Eur. J. Dermatol. 2, 48-51. doi: 10.1684/ejd.2011.1273
129. Masini, E., Blandina, P., and Mannaioni, P. F. (1982). Mast cell receptors controlling histamine release: influences on the mode of action of drugs used in the treatment of adverse drug reactions. Klin. Wochenschr. 60, 1031-1038. doi: 10.1007/BF01716967
130. Mayadas, T. N., Cullere, X., and Lowell, C. A. (2014). The multifaceted functions of neutrophils. Annu. Rev. Pathol. 9, 181-218. doi: 10.1146/annurev-pathol-020712-164023
131. Mayo, L., Quintana, F. J., and Weiner, H. L. (2012). The innate immune system in demyelinating disease. Immunol. Rev. 248, 170-187. doi: 10.1111/j.1600-065X.2012.01135.x
132. McNamee, E. N., Ryan, K. M., Kilroy, D., and Connor, T. J. (2010). Noradrenaline induces IL-1ra and IL-1 type II receptor expression in primary glial cells and protects against IL-1beta-induced neurotoxicity. Eur. J. Pharmacol. 626, 219-228. doi: 10.1016/j.ejphar.2009.09.054
133. Mellman, I., and Steinman, R. M. (2001). Dendritic cells: specialized and regulated antigen processing machines. Cell 106, 255-258. doi: 10.1016/S0092-8674(01)00449-4
134. Mencia-Huerta, J. M., Paul-Eugène, N., Dugas, B., Petit-Frère, C., Gordon, J., Lagente, V., et al. (1991). Beta-2-adrenoceptor agonists up-regulate the in vitro Fc epsilon receptor II/CD23 expression on, and release from, the promonocytic cell line U937 and human blood monocytes. Int. Arch. Allergy Appl. Immunol. 94, 91-92.
135. Merad, M., Manz, M. G., Karsunky, H., Wagers, A., Peters, W., Charo, I., et al. (2002). Langerhans cells renew in the skin throughout life under steady-state conditions. Nat. Immunol. 3, 1135-1141. doi: 10.1038/ni852
136. Miadonna, A., Tedeschi, A., Leggieri, E., Parravicini, P., Lorini, M., and Zanussi, C. (1989). Clonidine inhibits IgE-mediated and IgE-independent in vitro histamine release from human basophil leukocytes. Int. J. Immunopharmacol. 11, 473-477. doi: 10.1016/0192-0561(89)90176-8
137. Miksa, M., Wu, R., Zhou, M., and Wang, P. (2005). Sympathetic excitotoxicity in sepsis: pro-inflammatory priming of macrophages by norepinephrine. Front. Biosci. 10, 2217-2229. doi: 10.2741/1691
138. Mishima, K., Otani, H., Tanabe, T., Kawasaki, H., Oshiro, A., Saito, N., et al. (2001). Molecular mechanisms for alphα2-adrenoceptor-mediated regulation of synoviocyte populations. Jpn. J. Pharmacol. 85, 214-226. doi: 10.1254/jjp.85.214
139. Mizuno, K., Takahashi, H. K., Iwagaki, H., Katsuno, G., Kamurul, H. A., Ohtani, S., et al. (2005). Betα2-adrenergic receptor stimulation inhibits LPS-induced IL-18 and IL-12 production in monocytes. Immunol. Lett. 101, 168-172. doi: 10.1016/j.imlet.2005.05.008
140. Mócsai, A. (2013). Diverse novel functions of neutrophils in immunity, inflammation, and beyond. J. Exp. Med. 210, 1283-1299. doi: 10.1084/jem.20122220
141. Motojima, S., Fukuda, T., and Makino, S. (1992). Effect of eosinophil peroxidase on beta-adrenergic receptor density on guinea pig lung membrane. Biochem. Biophys. Res. Commun. 189, 1613-1619. doi: 10.1016/0006-291X(92)90261-I
142. Munoz, N. M., Vita, A. J., Neeley, S. P., McAllister, K., Spaethe, S. M., White, S. R., et al. (1994). Beta adrenergic modulation of formyl-methionine-leucine-phenylalanine-stimulated secretion of eosinophil peroxidase and leukotriene C4. J. Pharmacol. Exp. Ther. 268, 139-143.
143. Musgrave, I. F., and Seifert, R. (1994). Human neutrophils and HL-60 cells do not possess alpha 2-adrenoceptors. Biochem Pharmacol. 47, 233-239. doi: 10.1016/0006-2952(94)90011-6
144. Nguyen, K. D., Qiu, Y., Cui, X., Goh, Y. P., Mwangi, J., David, T., et al. (2011). Alternatively activated macrophages produce catecholamines to sustain adaptive thermogenesis. Nature 480, 104-108. doi: 10.1038/nature10653
145. Nielson, C. P. (1987). Beta-adrenergic modulation of the polymorphonuclear leukocyte respiratory burst is dependent upon the mechanism of cell activation. J. Immunol. 139, 2392-2397.
146. Nijhuis, L. E., Olivier, B. J., Dhawan, S., Hilbers, F. W., Boon, L., Wolkers, M. C., et al. (2014). Adrenergic β2 receptor activation stimulates anti-inflammatory properties of dendritic cells in vitro. PLoS ONE 9:e85086. doi: 10.1371/journal.pone.0085086
147. Noris, M., and Remuzzi, G. (2013). Overview of complement activation and regulation. Semin. Nephrol. 33, 479-492. doi: 10.1016/j.semnephrol.2013.08.001
148. O'Reilly, S. (2014). Innate immunity in systemic sclerosis pathogenesis. Clin. Sci. 126, 329-337. doi: 10.1042/CS20130367
149. Page, G. G., and Ben-Eliyahu, S. (2000). Natural killer cell activity and resistance to tumor metastasis in prepubescent rats: deficient baselines, but invulnerability to stress and beta-adrenergic stimulation. Neuroimmunomodulation 7, 160-168. doi: 10.1159/000026434
150. Page, G. G., Fennelly, A. M., Littleton-Kearney, M. T., and Ben-Eliyahu, S. (2008). Male-female differences in the impact of beta-adrenoceptor stimulation on resistance to experimental metastasis: exploring the effects of age and gonadal hormone involvement. J. Neuroimmunol. 193, 113-119. doi: 10.1016/j.jneuroim.2007.10.023
151. Panina-Bordignon, P., Mazzeo, D., Lucia, P. D., D'Ambrosio, D., Lang, R., Fabbri, L., et al. (1997). Betα2-agonists prevent Th1 development by selective inhibition of interleukin 12. J. Clin. Invest. 100, 1513-1519.
152. Paul-Eugène, N., Kolb, J. P., Calenda, A., Gordon, J., Kikutani, H., Kishimoto, T., et al. (1993). Functional interaction between beta 2-adrenoceptor agonists and interleukin-4 in the regulation of CD23 expression and release and IgE production in human. Mol. Immunol. 30, 157-164.
153. Paul-Eugène, N., Kolb, J. P., Abadie, A., Gordon, J., Delespesse, G., Sarfati, M., et al. (1992). Ligation of CD23 triggers cAMP generation and release of inflammatory mediators in human monocytes. J. Immunol. 149, 3066-3071.
154. Paul-Eugène, N., Kolb, J. P., Damais, C., Abadie, A., Mencia-Huerta, J. M., Braquet, P., et al. (1994). Beta 2-adrenoceptor agonists regulate the IL-4-induced phenotypical changes and IgE-dependent functions in normal human monocytes. J. Leukoc. Biol. 55, 313-320.
155. Pedersen, P., Hasselgren, P. O., Angerås, U., Hall-Angerås, M., Warner, B. W., LaFrance, R., et al. (1989). Protein synthesis in liver following infusion of the catabolic hormones corticosterone, epinephrine, and glucagon in rats. Metabolism 38, 927-932. doi: 10.1016/0026-0495(89)90001-2
156. Pohl, A., Otto, J., and Urbanek, R. (1991). Beta-2-adrenoceptors of polymorphonuclear leukocytes in children with atopic dermatitis. Their number and affinity to the radioligand [125I]-cyanopindolol. Int. Arch. Allergy Appl. Immunol. 95, 261-265. doi: 10.1159/000235439
157. Powe, D. G., Voss, M. J., Zänker, K. S., Habashy, H. O., Green, A. R., Ellis, I. O., et al. (2010). Beta-blocker drug therapy reduces secondary cancer formation in breast cancer and improves cancer specific survival. Oncotarget 1, 628-638.
158. Prey, S., Leaute-Labreze, C., Pain, C., Moisan, F., Vergnesm, P., Loot, M., et al. (2014). Mast cells as possible targets of propranolol therapy: an immunohistological study of beta-adrenergic receptors in infantile haemangiomas. Histopathology 65, 436-439. doi: 10.1111/his.12421
159. Prösch, S., Wendt, C. E., Reinke, P., Priemer, C., Oppert, M., Krüger, D. H., et al. (2000). A novel link between stress and human cytomegalovirus (HCMV) infection: sympathetic hyperactivity stimulates HCMV activation. Virology 272, 357-365. doi: 10.1006/viro.2000.0367
160. Radojcic, T., Baird, S., Darko, D., Smith, D., and Bulloch, K. (1991). Changes in beta-adrenergic receptor distribution on immunocytes during differentiation: an analysis of T cells and macrophages. J. Neurosci. Res. 30, 328-335.
161. Rainer, T. H., Lam, N., and Cocks, R. A. (1999). Adrenaline upregulates monocyte L-selectin in vitro. Resuscitation 43, 47-55.
162. Ramsay, C. E., Hayden, C. M., Tiller, K. J., Burton, P. R., Hagel, I., Palenque, M., et al. (1999). Association of polymorphisms in the betα2-adrenoreceptor gene with higher levels of parasitic infection. Hum. Genet. 104, 269-274. doi: 10.1007/s004390050947
163. Ratge, D., Wiedemann, A., Kohse, K. P., and Wisser, H. (1988). Alterations of beta-adrenoceptors on human leukocyte subsets induced by dynamic exercise: effect of prednisone. Clin. Exp. Pharmacol. Physiol. 15, 43-53. doi: 10.1111/j.1440-1681.1988.tb01007.x
164. Riepl, B., Grässel, S., Wiest, R., Fleck, M., and Straub, R. H. (2010). Tumor necrosis factor and norepinephrine lower the levels of human neutrophil peptides 1-3 secretion by mixed synovial tissue cultures in osteoarthritis and rheumatoid arthritis. Arthritis Res. Ther. 12, R110. doi: 10.1186/ar3044
165. Rosenne, E., Sorski, L., Shaashua, L., Neeman, E., Matzner, P., Levi, B., et al. (2014). In vivo suppression of NK cell cytotoxicity by stress and surgery: glucocorticoids have a minor role compared to catecholamines and prostaglandins. Brain Behav. Immun. 37:207-219. doi: 10.1016/j.bbi.2013.12.007
166. Rouppe van der Voort, C., Kavelaars, A., van de Pol, M., and Heijnen, C. J. (1999). Neuroendocrine mediators up-regulate alpha1b- and alpha1d-adrenergic receptor subtypes in human monocytes. J. Neuroimmunol. 95, 165-173. doi: 10.1016/S0165-5728(99)00011-9
167. Rouppe van der Voort, C., Kavelaars, A., van de Pol, M., and Heijnen, C. J. (2000). Noradrenaline induces the phosphorylation of ERK-2 in human peripheral blood mononuclear cells after induction of α1-adrenergic receptors. J. Neuroimmunol. 108, 82-91. doi: 10.1016/s0165-5728(00)00253-8
168. Sarigianni, M., Bekiari, E., Tsapas, A., Konstantinidis, D., Kaloyianni, M., Koliakos, G., et al. (2011). Effect of epinephrine and insulin resistance on human monocytes obtained from lean and obese healthy participants: a pilot study. Angiology 62, 38-45. doi: 10.1177/0003319710371616
169. Saxena, M., and Yeretssian, G. (2014). NOD-Like receptors: master regulators of inflammation and cancer. Front. Immunol. 5:327. doi: 10.3389/fimmu.2014.00327
170. Scanzano, A., Schembri, L., Rasini, E., Luini, A., Dallatorre, J., Legnaro, M., et al. (2015). Adrenergic modulation of migration, CD11b and CD18 expression, ROS and interleukin-8 production by human polymorphonuclear leukocytes. Inflamm. Res. 64, 127-135. doi: 10.1007/s00011-014-0791-8
171. Schedlowski, M., Hosch, W., Oberbeck, R., Benschop, R. J., Jacobs, R., Raab, H. R., et al. (1996). Catecholamines modulate human NK cell circulation and function via spleen-independent beta 2-adrenergic mechanisms. J. Immunol. 156, 93-99.
172. Schopf, R. E., and Lemmel, E. M. (1983). Control of the production of oxygen intermediates of human polymorphonuclear leukocytes and monocytes by beta-adrenergic receptors. J. Immunopharmacol. 5, 203-216. doi: 10.3109/08923978309039106
173. Schulze, W., and Fu, M. L. (1996). Localization of alpha 1-adrenoceptors in rat and human hearts by immunocytochemistry. Mol. Cell. Biochem. 163-164, 159-165. doi: 10.1007/BF00408653
174. Schupf, N., Williams, C. A., Berkman, A., Cattell, W. S., and Kerper, L. (1989). Binding specificity and presynaptic action of anaphylatoxin C5a in rat brain. Brain Behav. Immun. 3, 28-38. doi: 10.1016/0889-1591(89)90003-2
175. Schwab, K. O., Bartels, H., Martin, C., and Leichtenschlag, E. M. (1993). Decreased beta 2-adrenoceptor density and decreased isoproterenol induced c-AMP increase in juvenile type I diabetes mellitus: an additional cause of severe hypoglycaemia in childhood diabetes? Eur. J. Pediatr. 152, 797-801. doi: 10.1007/BF02073373
176. Serbina, N. V., Jia, T., Hohl, T. M., and Pamer, E. G. (2008). Monocyte-mediated defense against microbial pathogens. Annu. Rev. Immunol. 26, 421. doi: 10.1146/annurev.immunol.26.021607.090326
177. Shah, S. M., Carey, I. M., Owen, C. G., Harris, T., Dewilde, S., and Cook, D. G. (2011). Does β-adrenoceptor blocker therapy improve cancer survival? Findings from a population-based retrospective cohort study. Br. J. Clin. Pharmacol. 72, 157-161. doi: 10.1111/j.1365-2125.2011.03980.x
178. Shakhar, G., and Ben-Eliyahu, S. (1998). In vivo beta-adrenergic stimulation suppresses natural killer activity and compromises resistance to tumor metastasis in rats. J. Immunol. 160, 3251-3258.
179. Sloan, E. K., Priceman, S. J., Cox, B. F., Yu, S., Pimentel, M. A., Tangkanangnukul, V., et al. (2010). The sympathetic nervous system induces a metastatic switch in primary breast cancer. Cancer Res. 70, 7042-7052. doi: 10.1158/0008-5472.CAN-10-0522
180. Sofroniew, M. V., and Vinters, H. V. (2010). Astrcotys: biology and pathology. Acta Neuropathol. 119, 7-35. doi: 10.1007/s00401-009-0619-8
181. Speidl, W. S., Toller, W. G., Kaun, C., Weiss, T. W., Pfaffenberger, S., Kastl, S. P., et al. (2004). Catecholamines potentiate LPS-induced expression of MMP-1 and MMP-9 in human monocytes and in the human monocytic cell line U937: possible implications for peri-operative plaque instability. FASEB J. 18, 603-605. doi: 10.1096/fj.03-0454fje
182. Spencer, H., Karavolos, M. H., Bulmer, D. M., Aldridge, P., Chhabra, S. R., Winzer, K., et al. (2010). Genome-wide transposon mutagenesis identifies a role for host neuroendocrine stress hormones in regulating the expression of virulence genes in Salmonella. J. Bacteriol. 192, 714-724. doi: 10.1128/JB.01329-09
183. Spengler, R. N., Chensue, S. W., Giacherio, D. A., Blenk, N., and Kunkel, S. L. (1994). Endogenous norepinephrine regulates tumor necrosis factor-alpha production from macrophages in vitro. J. Immunol. 152, 3024-3031.
184. Spits, H., Artis, D., Colonna, M., Diefenbach, A., Di Santo, J. P., Eberl, G., et al. (2013). Innate lymphoid cells-a proposal for uniform nomenclature. Nat. Rev. Immunol. 13, 145-149. doi: 10.1038/nri3365
185. Spooren, A., Mestdagh, P., Rondou, P., Kolmus, K., Haegeman, G., and Gerlo, S. (2011). IL-1β potently stabilizes IL-6 mRNA in human astrocytes. Biochem. Pharmacol. 81, 1004-1015. doi: 10.1016/j.bcp.2011.01.019
186. Stefanski, V., and Ben-Eliyahu, S. (1996). Social confrontation and tumor metastasis in rats: defeat and beta-adrenergic mechanisms. Physiol. Behav. 60, 277-282.
187. Straub, R. H. (2004). Complexity of the bi-directional neuroimmune junction in the spleen. Trends Pharmacol. Sci. 25, 640-646. doi: 10.1016/j.tips.2004.10.007
188. Suchánek, O., Podrazil, M., Fischerová, B., Boèínská, H., Budínski, V., Stejskal, D., et al. (2010). Intensive physical activity increases peripheral blood dendritic cells. Cell. Immunol. 266, 40-45. doi: 10.1016/j.cellimm.2010.08.010
189. Swirski, F. K., and Nahrendorf, M. (2013). Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure. Science 339, 161-166. doi: 10.1126/science.1230719
190. Szelenyi, J., Selmeczy, Z., Brozik, A., Medgyesi, D., and Magocsi, M. (2006). Dual beta-adrenergic modulation in the immune system: stimulus-dependent effect of isoproterenol on MAPK activation and inflammatory mediator production in macrophages. Neurochem. Int. 49, 94-103. doi: 10.1016/j.neuint.2006.01.009
191. Tachibana, A., Kato, M., Kimura, H., Fujiu, T., Suzuki, M., and Morikawa, A. (2002). Inhibition by fenoterol of human eosinophil functions including betα2-adrenoceptor-independent actions. Clin. Exp. Immunol. 130, 415-423. doi: 10.1046/j.1365-2249.2002.01997.x
192. Takahashi, H. K., Morichika, T., Iwagaki, H., Yoshino, T., Tamura, R., Saito, S., et al. (2003). Effect of beta 2-adrenergic receptor stimulation on interleukin-18-induced intercellular adhesion molecule-1 expression and cytokine production. J. Pharmacol. Exp. Ther. 304, 634-642. doi: 10.1124/jpet.102.042622
193. Takamoto, T., Hori, Y., Koga, Y., Toshima, H., Hara, A., and Yokoyama, M. M. (1991). Norepinephrine inhibits human natural killer cell activity in vitro. Int. J. Neurosci. 58, 127-131.
194. Tarr, A. J., Powell, N. D., Reader, B. F., Bhave, N. S., Roloson, A. L., Carson, W. E. III, et al. (2012). β-Adrenergic receptor mediated increases in activation and function of natural killer cells following repeated social disruption. Brain Behav. Immun. 26, 1226-1238. doi: 10.1016/j.bbi.2012.07.002
195. Theorell, J., Gustavsson, A. L., Tesi, B., Sigmundsson, K., Ljunggren, H. G., Lundbäck, T., et al. (2014). Immunomodulatory activity of commonly used drugs on Fc-receptor-mediated human natural killer cell activation. Cancer Immunol. Immunother. 63, 627-641. doi: 10.1007/s00262-014-1539-6
196. Tomozawa, Y., Yabuuchi, K., Inoue, T., and Satoh, M. (1995). Participation of cAMP and cAMP-dependent protein kinase in beta-adrenoceptor-mediated interleukin-1 beta mRNA induction in cultured microglia. Neurosci. Res. 22, 399-409. doi: 10.1016/0168-0102(95)00922-G
197. Trabold, B., Lunz, D., Gruber, M., Fröhlich, D., and Graf, B. (2010). Immunomodulation of neutrophil-endothelial interaction by inotropes. Injury 41, 1079-1083. doi: 10.1016/j.injury.2010.05.034
198. Ueshima, H., Inada, T., and Shingu, K. (2013). Suppression of phagosome proteolysis and Matrigel migration with the α2-adrenergic receptor agonist dexmedetomidine in murine dendritic cells. Immunopharmacol. Immunotoxicol. 35, 558-566. doi: 10.3109/08923973.2013.822509
199. Vago, T., Norbiato, G., Baldi, G., Chebat, E., Bertora, P., and Bevilacqua, M. (1990). Respiratory-burst stimulants desensitize beta-2 adrenoceptors on human polymorphonuclear leukocytes. Int. J. Tissue React. 12, 53-58.
200. Vasin, M. V., and Kuznetsova, L. N. (1995). Change in the functional activity of the blood complement system after administration of adrenaline to animals. Patol. Fiziol. Eksp. Ter. 3, 16-18.
201. Wahle, M., Greulich, T., Baerwald, C. G., Häntzschel, H., and Kaufmann, A. (2005). Influence of catecholamines on cytokine production and expression of adhesion molecules of human neutrophils in vitro. Immunobiology 210, 43-52. doi: 10.1016/j.imbio.2005.02.004
202. Wallace, L. J., Partlow, L. M., Ellis, M. E., and Woodbury, D. M. (1976). Alpha-adrenergic regulation of the secretion of an anticomplementary factor in mouse saliva. Proc. Soc. Exp. Biol. Med. 152, 99-104. doi: 10.3181/00379727-152-39337
203. Wang, J., Li, J., Sheng, X., Zhao, H., Cao, X. D., Wang, Y. Q., et al. (2010). Beta-adrenoceptor mediated surgery-induced production of pro-inflammatory cytokines in rat microglia cells. J. Neuroimmunol. 223, 77-83. doi: 10.1016/j.jneuroim.2010.04.006
204. Wang, X. S., and Lau, H. Y. (2006). Beta-adrenoceptor-mediated inhibition of mediator release from human peripheral blood-derived mast cells. Clin. Exp. Pharmacol. Physiol. 33, 746-750. doi: 10.1111/j.1440-1681.2006.04435.x
205. Whalen, M. M., and Bankhurst, A. D. (1990). Effects of beta-adrenergic receptor activation, cholera toxin and forskolin on human natural killer cell function. Biochem. J. 272, 327-331.
206. Williams, C. A., Schupf, N., and Hugli, T. E. (1985). Anaphylatoxin C5a modulation of an alpha-adrenergic receptor system in the rat hypothalamus. J. Neuroimmunol. 9, 29-40. doi: 10.1016/S0165-5728(85)80004-7
207. Wrona, D. (2006). Neural-immune interactions: an integrative view of the bidirectional relationship between the brain and immune systems. J. Neuroimmunol. 172, 38-58. doi: 10.1016/j.jneuroim.2005.10.017
208. Xiao, J., Huang, H. W., Peng, Y. P., Bao, J. Y., Huang, Y., and Qiu, Y. H. (2010). Modulation of natural killer cell function by alpha-adrenoreceptor-coupled signalling. Neuro Endocrinol. Lett. 31, 635-644.
209. Xu, B., Zhang, W. S., Yang, J. L., Lu, N., Deng, X. M., Xu, H., et al. (2010). Evidence for suppression of spinal glial activation by dexmedetomidine in a rat model of monoarthritis. Clin. Exp. Pharmacol. Physiol. 37, e158-e166. doi: 10.1111/j.1440-1681.2010.05426.x
210. Xu, Z., Hirasawa, A., Shinoura, H., and Tsujimoto, G. (1999). Interaction of the alpha(1B)-adrenergic receptor with gC1q-R, a multifunctional protein. J. Biol. Chem. 274, 21149-21154. doi: 10.1074/jbc.274.30.21149
211. Yanagawa, Y., Matsumoto, M., and Togashi, H. (2010). Enhanced dendritic cell antigen uptake via alpha2 adrenoceptor-mediated PI3K activation following brief exposure to noradrenaline. J. Immunol. 185, 5762-5768. doi: 10.4049/jimmunol.1001899
212. Yanagawa, Y., Matsumoto, M., and Togashi, H. (2011). Adrenoceptor-mediated enhancement of interleukin-33 production by dendritic cells. Brain Behav. Immun. 25, 1427-1433. doi: 10.1016/j.bbi.2011.04.012
213. Yang, H., Du, R. Z., Qiu, J. P., Tang, Y. Q., and Chen, S. C. (2013). Bisoprolol reverses epinephrine-mediated inhibition of cell emigration through increases in the expression of β-arrestin 2 and CCR7 and PI3K phosphorylation, in dendritic cells loaded with cholesterol. Thromb. Res. 131, 230-237. doi: 10.1016/j.thromres.2012.12.009
214. Yang, J. H., Lee, E. O., Kim, S. E., Suh, Y. H., and Chong, Y. H. (2012). Norepinephrine differentially modulates the innate inflammatory response provoked by amyloid-β peptide via action at β-adrenoceptors and activation of cAMP/PKA pathway in human THP-1 macrophages. Exp. Neurol. 236, 199-206. doi: 10.1016/j.expneurol.2012.05.008
215. Yokoyama, W. M. (2005). Natural killer cell immune responses. Immunol. Res. 32, 317-325. doi: 10.1385/IR:32:1-3:317
216. Yona, S., Kim, K. W., Wolf, Y., Mildner, A., Varol, D., Breker, M., et al. (2013). Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity 38, 79-91. doi: 10.1016/j.immuni.2012.12.001
217. Yukawa, T., Ukena, D., Kroegel, C., Chanez, P., Dent, G., Chung, K. F., et al. (1990). Beta 2-adrenergic receptors on eosinophils. Binding and functional studies. Am. Rev. Respir. Dis. 141, 1446-1452. doi: 10.1164/ajrccm/141.6.1446
218. Zeinstra, E., Wilczak, N., and De Keyser, J. (2000). [3H]dihydroalprenolol binding to beta adrenergic receptors in multiple sclerosis brain. Neurosci. Lett. 289, 75-77. doi: 10.1016/S0304-3940(00)01254-4